RADIAN®
Gilead's RADIAN® initiative funds innovative, community-based projects to improve HIV testing, care, and prevention in Eastern Europe and Central Asia.
Funder: Gilead Sciences
Due Dates (Anticipated): June 2026 (Application deadline, projected)
Funding Amounts: Funding amounts not specified; varies by project and initiative.
Summary: Supports projects expanding HIV testing, care, and prevention in Eastern Europe and Central Asia through innovative, community-focused approaches.
Description
RADIAN® is a strategic initiative by Gilead Sciences aimed at addressing the HIV epidemic in Eastern Europe and Central Asia. The program supports organizations and projects that increase access to HIV testing, improve HIV treatment and care delivery, and enhance prevention programs—especially through community-based and innovative approaches. By fostering partnerships with organizations working on the front lines, RADIAN® seeks to make a measurable impact on HIV outcomes in the region.
